Pallas Capital Advisors LLC 10x Genomics, Inc. Transaction History
Pallas Capital Advisors LLC
- $2.43 Billion
- Q2 2025
A detailed history of Pallas Capital Advisors LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 56,776 shares of TXG stock, worth $706,861. This represents 0.03% of its overall portfolio holdings.
Number of Shares
56,776
Previous 23,780
138.76%
Holding current value
$706,861
Previous $207,000
217.39%
% of portfolio
0.03%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding TXG
# of Institutions
302Shares Held
109MCall Options Held
228KPut Options Held
157K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.8MShares$160 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$138 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL7.1MShares$88.4 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$79.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.38MShares$66.9 Million0.03% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.18B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...